Johnson & Johnson (JNJ) Price to Sales (2009 - 2026)

Johnson & Johnson has disclosed Price to Sales across 18 years of filings, most recently posting 24.25 for Q2 2026.

• In Q2 2026, Price to Sales rose 56.85% year-over-year to 24.25; the TTM figure through Jun 2026 stood at 6.27 (up 54.73% YoY), while the FY2025 annual figure was 5.31, up 35.11% from the prior year.
• Price to Sales came in at 24.25 for Q2 2026 at Johnson & Johnson, up from 24.06 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 24.25 in Q2 2026 to a low of 15.46 in Q2 2025.
• Average Price to Sales over 5 years is 19.57, with a median of 18.66 recorded in 2023.
• Year-over-year, Price to Sales declined 23.52% in 2023 and surged 56.85% in 2026.
• Over 5 years, Price to Sales stood at 21.36 in 2022, then slipped by 17.38% to 17.65 in 2023, then retreated by 12.12% to 15.51 in 2024, then soared by 31.36% to 20.37 in 2025, then climbed by 19.04% to 24.25 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 24.25 in Q2 2026, 24.06 in Q1 2026, and 20.37 in Q4 2025.